Invasive pneumococcal disease is an uncommon and notifiable disease in Singapore. It is often associated with significant morbidity and mortality. We report a rare case of invasive pneumococcal bacteraemia due to parotitis in a patient with systemic sclerosis and secondary Sjögren’s syndrome. We also present a retrospective review of Streptococcus pneumoniae bacteraemia cases in Singapore General Hospital from January 2011 to April 2016.
Case presentation:
A 59-year-old Malay lady with a history of systemic sclerosis with secondary Sjögren’s syndrome presented with fever and left parotid gland swelling. Clinical examination revealed poor salivary pooling and left parotid swelling without fluctuance. Ultrasound of the left parotid gland confirmed acute parotitis without evidence of abscess or sialolithiasis. Blood cultures were positive for S. pneumoniae. She was diagnosed to have invasive pneumococcal bacteraemia secondary to acute parotitis, and treated with intravenous benzylpenicillin with clearance of bacteraemia after 3 days. Upon discharge, her antibiotics were changed to intravenous ceftriaxone to facilitate outpatient parenteral antibiotic therapy for another 2 weeks. She responded favourably to antibiotics at follow-up, with no complications from the bacteraemia. A review of the microbiological records of the Singapore General Hospital revealed 116 cases of pneumococcal bacteraemia, most (80.3 %) of which were due to pneumonia. None were due to parotitis.
Conclusion:
S. pneumoniae parotitis and subsequent bacteraemia is rare. Prompt recognition of the disease and appropriate use of antibiotics are important. This case highlights that close communication between healthcare workers (microbiologist, rheumatologist and infectious disease specialist) is essential in ensuring good clinical outcomes in patients with a potentially fatal disease.
This is an open access article under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
BontenM. J.,
HuijtsS. M.,
BolkenbaasM.,
WebberC.,
PattersonS.,
GaultS.,
van WerkhovenC. H.,
van DeursenA. M.,
SandersE. A. et al.2015; Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 372:1114–1125 [View Article][PubMed]
CDC2010; Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 59:1102–1106[PubMed]
CDC2012; Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 61:816–819[PubMed]
GentileJ. H.,
SparoM. D.,
MercapideM. E.,
LunaC. M.2003; Adult bacteremic pneumococcal pneumonia acquired in the community. A prospective study on 101 patients. Medicina 63:9–14[PubMed]
HanekomW. A.,
ChadwickE. G.,
YogevR.1995; Pneumococcal parotitis in a human immunodeficiency virus-infected child. Pediatr Infect Dis J 14:1113–1114[PubMed][CrossRef]
JacksonL. A.,
NeuzilK. M.,
YuO.,
BensonP.,
BarlowW. E.,
AdamsA. L.,
HansonC. A.,
MahoneyL. D.,
ShayD. K. et al.2003; Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 348:1747–1755 [View Article][PubMed]
KobayashiM.,
BennettN. M.,
GierkeR.,
AlmendaresO.,
MooreM. R.,
WhitneyC. G.,
PilishviliT.2015; Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 64:944–947 [View Article][PubMed]
VinascoL. G.,
BaresS.,
SandkovskyU.2015; Acute suppurative parotitis caused by Streptococcus pneumoniae in an HIV-infected man. BMJ Case Reports 2015:bcr-2014-209082[CrossRef]
WottonC. J.,
GoldacreM. J.2012; Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Community Health 66:1177–1181 [View Article][PubMed]